Rani Therapeutics Holdings, Inc.

RANI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,762$5,864$27,007$117,453
Short-Term Investments$23,877$42,675$71,475$0
Receivables$428$200$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,677$2,108$2,442$2,142
Total Curr. Assets$29,744$50,847$100,924$119,595
Property Plant & Equip (Net)$6,644$6,823$7,103$4,612
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$246$246$0$0
Total NC Assets$6,890$7,069$7,103$4,612
Other Assets$0$0$0$0
Total Assets$36,634$57,916$108,027$124,207
Liabilities
Payables$1,359$648$1,460$1,080
Short-Term Debt$16,459$5,615$1,006$0
Tax Payable$0$0$0$0
Deferred Revenue$0$1,211$0$0
Other Curr. Liab.$2,073$515$2,349$1,560
Total Curr. Liab.$19,891$7,989$4,815$2,640
LT Debt$13,250$24,484$29,208$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$13,250$24,484$29,208$0
Other Liabilities$0$0$0$0
Cap. Leases$5,096$718$1,065$0
Total Liabilities$33,141$32,473$34,023$2,640
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$102,907-$72,889-$38,919-$8,331
AOCI$5-$12-$73-$0
Other Equity$104,889$85,762$75,842$55,737
Total Equity$1,992$12,866$36,855$47,411
Supplemental Information
Minority Interest$1,501$12,577$37,149$74,156
Total Liab. & Tot. Equity$36,634$57,916$108,027$124,207
Net Debt$25,947$24,235$3,207-$117,453
Rani Therapeutics Holdings, Inc. (RANI) Financial Statements & Key Stats | AlphaPilot